SEC Form D · filed March 17, 2020
Primmune Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Charles Mcdermott · San Diego, CAExec · DirectorScott S. Morenstein · San Diego, CADirectorTodd J. Harris · San Diego, CADirectorPaulo S. Rangel · San Diego, CAExec · DirectorJames R. Appleman · San Diego, CAExec · DirectorChristopher Mccoy · New York, NYDirectorStoyan Hadjivaltchev · New York, NYExec · DirectorDaniel Curran · Waltham, MAExec · DirectorJack Belsito · Newport Beach, CADirectorJames R. Appleman · San Diego, CAExec · DirectorAlex Hoffman · Toronto, Ontario, CanadaExec · DirectorAngela Kattoula · Toronto, Ontario, CanadaExec · DirectorDarren Collins · Toronto, Ontario, CanadaDirectorPeter Simeon · Toronto, Ontario, CanadaExec · DirectorBarry A. Kaplan · Greenwich, CTDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗